The search for HAT and HDAC isoforms that are capable of acetylating/deacetylating the signaling proteins and transcription factors that regulate apoptosis and other essential functions of brain cells after stroke will contribute to the development of effective neuroprotective therapies based on selective iHDACs. This evidence concerns the gene TMPRSS11D and stroke disorder.